Truvestments Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.5K Hold
319
– – 0.01% 472
2026
Q1
$94.2K Buy
319
+2
+0.6% +$594 0.02% 391
2025
Q4
$86.7K Buy
317
+176
+125% +$47.8K 0.02% 362
2025
Q3
$38.1K Buy
141
+21
+18% +$5.71K 0.01% 480
2025
Q2
$33.2K Hold
120
– – 0.01% 468
2025
Q1
$31.8K Buy
120
+3
+3% +$740 0.01% 479
2024
Q4
$27.2K Hold
117
– – 0.01% 460
2024
Q3
$25.7K Buy
+117
New +$24.2K 0.01% 461
2019
Q2
– Sell
-193
Closed -$32K – 721
2019
Q1
$32K Buy
+193
New +$34.1K 0.02% 336
2018
Q3
$62K Buy
+363
New +$61.1K 0.03% 345

Other funds holding CME

Truvestments Capital's CME Position: Q2 2026 in Review

Truvestments Capital held its CME Group (CME) position steady in Q2 2026 at 319 shares worth $70.5K. The position accounts for 0.01% of the portfolio, ranked #472.

Truvestments Capital first reported a position in CME in Q3 2018 and has held it in 10 quarters since. The position peaked at $94.2K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Truvestments Capital held 319 shares of CME Group worth $70.5K as of Q2 2026.
  • Truvestments Capital left its CME Group share count unchanged in Q2 2026.
  • CME Group made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #472 holding.
  • Truvestments Capital first reported a position in CME Group in Q3 2018 and has held it in 10 quarters since.
  • Truvestments Capital's CME Group position peaked at $94.2K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.